BofA Securities, the investment banking arm of Bank of America, has issued a bullish call on Hinge Health, a digital musculoskeletal-care company, arguing that the firm could outpace Wall Street's current expectations. The upbeat assessment comes even as Hinge Health's shares recently traded at $91.78, a slight dip, suggesting the market may not yet fully price in the company's growth potential.
What's Driving the Optimism?
According to BofA, Hinge Health's growth story hinges on two key factors: rising member participation and the rollout of new products. The bank notes that more members are actively engaging with Hinge's programs, which are designed to help people manage chronic back, joint, and muscle pain through digital therapy, coaching, and wearable sensors. This increased engagement is critical because Hinge Health's business model relies on employers and health plans paying for access to its platform, and higher usage often translates into better outcomes and renewals.
Additionally, BofA points to a larger pool of "eligible lives"—the number of people covered through employer-sponsored plans who could potentially use Hinge's services. As more companies sign up, the addressable market expands, providing a solid foundation for future growth.
Billings Growth: A Key Metric
The bank's projections are notably aggressive. BofA sees billings—the dollar value of contracts signed during a period, which serves as a leading indicator for future revenue—growing by 45% in 2026. That growth is expected to moderate to 29% in 2027 and 25% in 2028, but even those figures are above consensus forecasts, according to the bank. Billings are important because they reflect new business momentum before it shows up in revenue, so strong billings growth today suggests robust revenue in the coming years.
BofA also highlights management's plan to add 4-5 million new eligible lives, a move that would significantly expand the company's reach. While the brief does not specify the exact timeline, such expansion would likely be a major driver of the projected growth.
Context: The Digital Health Landscape
Hinge Health operates in the rapidly growing digital health sector, which has seen increased adoption as employers and insurers seek cost-effective ways to manage chronic conditions. Musculoskeletal issues are among the most common and costly health problems, affecting millions of workers and leading to significant healthcare spending. Digital solutions like Hinge's offer a way to reduce costs while improving patient outcomes, making them attractive to employers.
The company's focus on engagement is particularly important. Many digital health platforms struggle with low user adoption, but Hinge's emphasis on active participation appears to be a differentiator. BofA's confidence suggests that Hinge has found a formula that works, which could bode well for its long-term prospects.
What It Means for Investors
For everyday investors, this analysis offers a glimpse into how Wall Street evaluates high-growth healthcare technology companies. The key takeaway is that Hinge Health's growth may be underestimated by the broader market. If BofA's projections prove accurate, the company could deliver revenue growth exceeding 20% for several years, which would likely support a higher stock price over time.
However, it's important to remember that forecasts are just that—forecasts. They are based on assumptions about member growth, product adoption, and market conditions that could change. Investors should consider the risks, including competition from other digital health providers, potential regulatory hurdles, and the challenge of sustaining high growth rates as the company scales.
Also, note that the stock's recent dip to $91.78 suggests some near-term volatility, which is common for growth stocks. For those with a long-term horizon, the BofA report provides a reason for optimism, but it's not a guarantee of future performance.
Looking Ahead
Investors will be watching Hinge Health's upcoming earnings reports for signs that the growth trajectory is on track. Key metrics to monitor include member engagement rates, the number of eligible lives added, and billings growth. Any updates on new product launches or major employer contracts could also move the stock.
In the broader market, tech and healthcare stocks have been sensitive to interest rates and inflation concerns, as seen in recent market moves where AI stocks lifted Wall Street despite headwinds. Hinge Health, as a growth-oriented company, could be similarly affected by macroeconomic factors.
For now, BofA's bullish stance adds to the narrative that Hinge Health is a company to watch. Whether it lives up to those expectations remains to be seen, but the underlying trends—rising participation and product innovation—are positive signs.
Conclusion
BofA Securities' outlook on Hinge Health is a vote of confidence in the company's ability to outgrow the market's expectations. With projected billings growth of 45% in 2026 and sustained revenue growth above 20%, the bank sees a bright future. For investors, this serves as a reminder to look beyond short-term price movements and focus on the fundamentals that drive long-term value.
